Jawbone is rethinking its strategy, as we have multiple publications discussing the future of one of the wearable device pioneers.
According to this Tech Insider article, the San Francisco-based company has, at least temporarily, ceased production of its Up2, Up3 and Up4 fitness bands; and has sold off all remaining inventory of the models to a reseller.
Another report, from Fortune, claims that Jawbone is trying to unload its wireless speaker business and focus exclusively on health and wearable devices.
Speaking of which, The Verge reports that Jawbone is working on a clinical-grade health tracking device related to heart monitoring. At this stage, it is unclear whether this will be another Up-branded wrist-worn product, or something completely different. The story does suggest that this upcoming device will be announced later this summer.
Earlier this year, Jawbone raised $165 million from the Kuwait Investment Authority to introduce new product(s) to the market, among other things. Some of that money could go towards launching that rumored, clinical-grade device, and some will undoubtedly go to legal fees as the company fights with Fitbit over activity tracking patents.